News
The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...
19h
News-Medical.Net on MSNTargeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trialThe HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...
Asthma incidence in adults is positively associated with lipid accumulation product (LAP) levels, according to study findings published in Respiratory Medicine.
The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results